Research progress on preclinical efficacy evaluation of COVID-19 complicated with cytokine storm
Chinese Pharmacological Bulletin
; 37(7):911-916, 2021.
Article
in Chinese
| Scopus | ID: covidwho-1792324
ABSTRACT
Studies have shown that COVID-19 patients infected with SARS-CoV-2 have severe pulmonary inflammation and cytokine storm, so the treatment of cytokine storm is an important part of rescuing critically ill patients with COVID-19. As an important cause of death, the preclinical study of cytokine storm is essential, and related experiments in vivo and in vitro are also the only way to develop new drugs for COVID-19 in the future. This paper reviews the in vitro and in vivo experimental methods of cytokine storm research articles at home and abroad in recent years, including the establishment of animal models, cell evaluation methods, pharmacodynamic evaluation indicators, etc., in order to provide reference and guidance for the experimental design methods of cytokine storm. © 2021 Publication Centre of Anhui Medical University. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Experimental Studies
Language:
Chinese
Journal:
Chinese Pharmacological Bulletin
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS